Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 54.96%4.5M | -12.09%28.99M | -38.11%7.58M | -19.65%6.32M | 49.11%12.18M | -38.00%2.91M | 47.60%32.97M | 33.69%12.25M | 80.13%7.87M | 8.98%8.17M |
Net income from continuing operations | 22.40%1.63M | 32.32%6.46M | -41.53%1.69M | 25.48%1.38M | 318.50%2.06M | 228.82%1.34M | 20.63%4.88M | 7.77%2.89M | 186.20%1.1M | -15.46%492K |
Operating gains losses | -32.73%2.03M | -6.48%11.15M | 91.94%2.6M | -3.50%2.81M | -32.72%2.72M | -16.32%3.02M | 147.52%11.92M | 187.66%1.35M | 70.41%2.91M | 129.28%4.05M |
Depreciation and amortization | 4.62%2.72M | -5.33%10.39M | 5.46%2.55M | -7.17%2.63M | -9.30%2.61M | -8.66%2.6M | -4.25%10.98M | -12.58%2.42M | 0.96%2.83M | -1.60%2.88M |
Deferred tax | ---33K | -218.18%-1.77M | -143.01%-668K | --0 | -900.00%-1.1M | --0 | -17.48%1.5M | -7.56%1.55M | --0 | -182.71%-110K |
Change In working capital | 49.36%-2.21M | -59.27%797K | -71.56%1.07M | -210.79%-832K | 20,595.83%4.92M | -71.41%-4.36M | 242.85%1.96M | 189.79%3.78M | 192.95%751K | -101.91%-24K |
-Change in receivables | 119.09%67K | -355.00%-306K | -25.59%474K | 100.47%1K | -209.35%-430K | -110.18%-351K | 132.17%120K | 75.00%637K | -97.20%-211K | 56.29%-139K |
-Change in payables and accrued expense | 42.12%-2.61M | -126.25%-795K | -99.76%11K | -42.58%387K | 391.99%3.32M | -57.66%-4.51M | 1,197.10%3.03M | 290.03%4.54M | 2,307.14%674K | -25.44%674K |
-Change in other current liabilities | -129.17%-7K | 95.85%-14K | 104.51%18K | -303.33%-61K | -68.75%5K | 50.00%24K | -359.23%-337K | -1,696.00%-399K | -62.03%30K | 366.67%16K |
-Change in other working capital | -27.97%340K | 323.89%1.91M | 156.99%571K | -549.22%-1.16M | 452.70%2.03M | 1.51%472K | -0.35%-854K | -300.80%-1M | 131.93%258K | -185.31%-575K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 54.96%4.5M | -12.09%28.99M | -38.11%7.58M | -19.65%6.32M | 49.11%12.18M | -38.00%2.91M | 47.60%32.97M | 33.69%12.25M | 80.13%7.87M | 8.98%8.17M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 114.92%1.08M | -3.84%-50.62M | 81.94%-3.65M | -394.42%-32.76M | 46.92%-6.99M | 17.48%-7.23M | -110.15%-48.75M | -502.77%-20.19M | 63.72%-6.63M | -6.18%-13.18M |
Net business purchase and sale | 391.02%3.57M | 102.14%804K | 104.44%595K | 129.39%1.28M | 101.30%155K | 84.25%-1.23M | -4,538.99%-37.48M | -299.82%-13.39M | 56.16%-4.35M | -855.46%-11.96M |
Net investment purchase and sale | ---- | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Net other investing changes | 199.02%613K | -391.49%-231K | 35.98%-137K | 205.11%537K | -251.26%-836K | -10.48%205K | -105.16%-47K | -0.94%-214K | -55.33%176K | -9.68%-238K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 114.92%1.08M | -3.84%-50.62M | 81.94%-3.65M | -394.42%-32.76M | 46.92%-6.99M | 17.48%-7.23M | -110.15%-48.75M | -502.77%-20.19M | 63.72%-6.63M | -6.18%-13.18M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -1,398.54%-11.27M | 404.85%12.7M | 100.75%4K | 909.65%14.19M | 57.93%-737K | -478.46%-752K | -124.75%-4.17M | -102.87%-532K | -197.96%-1.75M | -407.83%-1.75M |
Net issuance payments of debt | --718K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net common stock issuance | ---- | --0 | --0 | --0 | ---- | ---- | ---2M | --0 | ---1M | ---- |
Proceeds from stock option exercised by employees | ---- | -78.42%221K | 0.00%221K | --0 | --0 | --0 | 148.54%1.02M | 23.46%221K | --0 | --0 |
Net other financing activities | -1,494.02%-11.99M | 491.19%12.48M | 71.18%-217K | 1,986.30%14.19M | 1.99%-737K | 19.40%-752K | -119.43%-3.19M | -104.10%-753K | -27.89%-752K | -30.10%-752K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -1,398.54%-11.27M | 404.85%12.7M | 100.75%4K | 909.65%14.19M | 57.93%-737K | -478.46%-752K | -124.75%-4.17M | -102.87%-532K | -197.96%-1.75M | -407.83%-1.75M |
Net cash flow | ||||||||||
Beginning cash position | -5.67%148.62M | -11.24%157.56M | -12.86%144.68M | -5.77%156.93M | -12.01%152.48M | -11.24%157.56M | 9.89%177.5M | 14.67%166.03M | 4.57%166.54M | 5.33%173.3M |
Current changes in cash | -12.17%-5.69M | 55.20%-8.94M | 146.49%3.94M | -2,306.29%-12.25M | 165.73%4.45M | -20.80%-5.07M | -224.82%-19.94M | -125.90%-8.47M | 96.48%-509K | -28.53%-6.76M |
End cash Position | -6.26%142.93M | -5.67%148.62M | -5.67%148.62M | -12.86%144.68M | -5.77%156.93M | -12.01%152.48M | -11.24%157.56M | -11.24%157.56M | 14.67%166.03M | 4.57%166.54M |
Free cash flow | 54.96%4.5M | -12.09%28.99M | -38.11%7.58M | -19.65%6.32M | 49.11%12.18M | -38.00%2.91M | 47.60%32.97M | 33.69%12.25M | 80.13%7.87M | 8.98%8.17M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |